-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on CME Group, Raises Price Target to $270

Benzinga·10/05/2026 20:56:21
Listen to the news
UBS analyst Alex Kramm maintains CME Group (NASDAQ:CME) with a Neutral and raises the price target from $260 to $270.